Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02149264 · ClinicalTrials.gov registry record · Phase 3
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3 study, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 160
- Enrollment target
NCT02149264 is a Phase 3 study that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 160 participants.
The verdict
NCT02149264, a Phase 3 study, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 160 participants
- Enrollment target
Study Summary
This is a phase 3, open-label, non-randomized, clinical trial to evaluate the efficacy and safety of FE 999303 (Testosterone gel) in adult hypogonadal males.
Interventions
- DRUG Testosterone gel (FE 999303)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02149264
The ClinicalTrials.gov registry entry for NCT02149264 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ferring Pharmaceuticals, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Testosterone gel (FE 999303) is the first listed.
NCT02149264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02149264 about?
NCT02149264 is a clinical study titled "A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males". This is a phase 3, open-label, non-randomized, clinical trial to evaluate the efficacy and safety of FE 999303 (Testosterone gel) in adult hypogonadal males.
What is the current status of trial NCT02149264?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 160 participants. The study started on 2014-07. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02149264?
The interventions under investigation include: Testosterone gel (FE 999303) (DRUG).
Who is sponsoring clinical trial NCT02149264?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.